Histogenics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Histogenics and buy or sell other stocks, ETFs, and their options commission-free!About HSGX
Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions.
CEOAdam D. Gridley, MBA
CEOAdam D. Gridley, MBA
Employees95
Employees95
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2000
Founded2000
Employees95
Employees95
HSGX Key Statistics
Market cap144.29M
Market cap144.29M
Price-Earnings ratio-6.28
Price-Earnings ratio-6.28
Dividend yield—
Dividend yield—
Average volume3.30M
Average volume3.30M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.90
52 Week high$1.90
52 Week low$0.515
52 Week low$0.515
Stock Snapshot
The current Histogenics(HSGX) stock price is $0.46, with a market capitalization of 144.29M. The stock trades at a price-to-earnings (P/E) ratio of -6.28.
On 2025-12-14, Histogenics(HSGX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Histogenics(HSGX) stock has reached 0, versus its average volume of 3.3M.
The stock's 52-week range extends from a low of $0.52 to a high of $1.90.
The stock's 52-week range extends from a low of $0.52 to a high of $1.90.